Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Guardant Health (GH) Tops Q1 EPS by 26c, Updates Guidance
April 30, 2025 4:16 PM EDTGuardant Health (NASDAQ: GH) reported Q1 EPS of ($0.49), $0.26 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $203.5 million versus the consensus estimate of $190.01 million.
GUIDANCE:
Guardant Health sees FY2025 revenue of $880-890 million, versus the consensus of... More
